Clinical Cancer Research · 2012 · 75 citations · 5 references
MedicineCancer BiologyOncologyMedical OncologyTranslational MedicineTranslational OncologyBiomarker-guided Therapy SelectionCancer BiomarkersCancer Precision MedicineMalignant NeoplasmsPersonalized Cancer TherapyTranslational Cancer ResearchClinical Cancer DiagnosisPersonalized BiologicsPersonalized Cancer MedicinePersonalized Cancer TreatmentPersonalized Medicine BiomarkersPersonalized Treatment SelectionPrecision Oncology DiagnosticsPredictive Biomarker Assessment
The origins of this article stem from discussions at the American Association for Cancer Research Clinical and Translational Cancer Research Think Tank meeting held in San Francisco in early 2010. This article synthesizes the opinions and issues considered at that meeting, and discusses many of the important events that have since occurred in the field of personalized cancer medicine. Although investigators continue to make progress in better linking individual patient biology with risk determination, diagnosis, prognosis, and treatment selection, the pace of this progress continues to be limited by many of the issues identified in the meeting.
5
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman, Michael S. Lawrence, Jonathan J. Keats et al. · Nature · 2011 · 1.4K citations · Full text
Life Sciences, Genetics, Oncology +15
Warfarin Genotyping Reduces Hospitalization Rates
Robert S. Epstein, Thomas P. Moyer, Ronald E. Aubert et al. · Journal of the American College of Cardiology · 2010 · 336 citations
New clinical trials policy at FDA
Brian Vastag · Nature Biotechnology · 2006 · 17 citations
Patient-specific classifications of human malignant disease.
David Parkinson, Alessandra Cesano · PubMed · 2009 · 10 citations